Strides Pharma Science is currently trading at Rs. 468.00, up by 7.75 points or 1.68% from its previous closing of Rs. 460.25 on the BSE.
The scrip opened at Rs. 463.95 and has touched a high and low of Rs. 469.45 and Rs. 458.50 respectively. So far 58699 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 737.02 on 04-Apr-2018 and a 52 week low of Rs. 334.10 on 08-Jun-2018.
Last one week high and low of the scrip stood at Rs. 469.45 and Rs. 434.70 respectively. The current market cap of the company is Rs. 4158.68 crore.
The promoters holding in the company stood at 30.79%, while Institutions and Non-Institutions held 47.61% and 21.60% respectively.
Strides Pharma Science has received an approval from the shareholders for divestment of Australian Business and for Transactions/ Contracts/ Arrangements with Solara Active Pharma Sciences up to Rs 500 crore in each financial year, commencing from FY 2018-19.
Strides Pharma Science (Formerly Strides Shasun) is a pharmaceutical company with a major focus on development and manufacture of IP-led niche finished dosage formulations. It is also among the world’s largest manufacturers of soft gelatin capsules.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1849.05 |
Dr. Reddys Lab | 1274.25 |
Cipla | 1553.20 |
Lupin | 2184.00 |
Zydus Lifesciences | 1001.85 |
View more.. |